SEC 13F Intelligence

Baker Bros. Advisors LP / ABCL

Baker Bros. Advisors LP’s Abcellera Biologics Inc Position

Does Baker Bros. Advisors LP own Abcellera Biologics Inc (ABCL)? Yes — 30.28M shares worth $106M (+0.61% of its 13F portfolio) as of Q1 2026, up from 27.53M shares the prior filed quarter.

Position Value
$106M
Q1 2026
Shares
30.28M
% of Portfolio
+0.61%
Quarters Held
22
currently held

Position History ABCL

Reported value by quarter
Q4 ’20: $421MQ4 ’20Q1 ’21: $355MQ2 ’21: $230MQ3 ’21: $209MQ3 ’21Q4 ’21: $149MQ1 ’22: $102MQ2 ’22: $111MQ2 ’22Q3 ’22: $103MQ4 ’22: $106MQ1 ’23: $79MQ1 ’23Q2 ’23: $106MQ3 ’23: $96MQ4 ’23: $131MQ4 ’23Q1 ’24: $125MQ2 ’24: $81MQ3 ’24: $72MQ3 ’24Q4 ’24: $81MQ1 ’25: $61MQ2 ’25: $94MQ2 ’25Q3 ’25: $138MQ4 ’25: $94MQ1 ’26: $106MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202630.28M$106M+0.61%
Q4 202527.53M$94M+0.55%
Q3 202527.53M$138M+1.00%
Q2 202527.53M$94M+0.92%
Q1 202527.53M$61M+0.68%
Q4 202427.53M$81M+0.86%
Q3 202427.53M$72M+0.74%
Q2 202427.53M$81M+1.04%
Q1 202427.53M$125M+1.56%
Q4 202322.91M$131M+1.49%
Q3 202320.76M$96M+0.55%
Q2 202316.45M$106M+0.62%
Q1 202310.45M$79M+0.43%
Q4 202210.45M$106M+0.64%
Q3 202210.45M$103M+0.68%
Q2 202210.45M$111M+0.63%
Q1 202210.45M$102M+0.59%
Q4 202110.45M$149M+0.73%
Q3 202110.45M$209M+0.92%
Q2 202110.45M$230M+1.01%
Q1 202110.45M$355M+1.54%
Q4 202010.45M$421M+1.58%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Baker Bros. Advisors LP’s full portfolio or all institutional holders of ABCL.